Baidu
map

J Environ Manage:ZnO-GO或可用于多重耐药菌的处理

2019-08-29 不详 网络

一些纳米材料包括Fe0,Ag0和ZnO以其抗菌效果而众所周知。然而,很少有研究检测过纳米复合物的抗菌作用。鉴于已知金属氧化物(主要是ZnO和TiO2)与碳基纳米材料结合时会增加迁移率,表面积和光催化作用,因此研究了ZnO和TiO2共轭碳纳米管和氧化石墨烯纳米复合物对大肠杆菌的抗菌作用。 与基于碳纳米管(CNT)的纳米复合物(ZnO-CNT和TiO2 -CNT)相比,基于石墨烯-氧化物(GO)的纳米

一些纳米材料包括Fe0,Ag0和ZnO以其抗菌效果而众所周知。然而,很少有研究检测过纳米复合物的抗菌作用。鉴于已知金属氧化物(主要是ZnO和TiO2)与碳基纳米材料结合时会增加迁移率,表面积和光催化作用,因此研究了ZnO和TiO2共轭碳纳米管和氧化石墨烯纳米复合物对大肠杆菌的抗菌作用。

与基于碳纳米管(CNT)的纳米复合物(ZnO-CNT和TiO2 -CNT)相比,基于石墨烯-氧化物(GO)的纳米复合物(ZnO-GO和TiO 2 -GO)的分散性更好。在四种类型的纳米复合物中,ZnO-共轭的纳米复合物表现出更高的抗菌性,导致ZnO-GO> ZnO-CNT> TiO2-GO> TiO2-CNT的抗菌效果(通过细胞的生长抑制测量)。在四种可能的抗菌机制(活性氧(ROS)的产生,物理化学特性,空间效应和金属离子的释放)中,确定了主要机制-ROS产生;然而,物理化学特征和空间效应也是杀菌机制的一部分。由于表面积增加,TiO2/ZnO在GO上的分散增加可能有助于抗菌效果。类似地,GO片材以其锋利的边缘发现了对大肠杆菌细胞膜的明显损害。

我们的研究结果表明,应用GO基ZnO或TiO2是一种有效的抗菌方法,尤其适用于水中多重耐药细菌的处理。

原始出处:

Baek S, Joo SH, et al., Antibacterial effects of graphene- and carbon-nanotube-based nanohybrids on Escherichia coli: Implications for treating multidrug-resistant bacteria. J Environ Manage. 2019 Oct 1;247:214-223. doi: 10.1016/j.jenvman.2019.06.077. Epub 2019 Jun 24.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1633532, encodeId=f2f8163353236, content=<a href='/topic/show?id=377824e1c0' target=_blank style='color:#2F92EE;'>#ANA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2471, encryptionId=377824e1c0, topicName=ANA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=434d22047430, createdName=AspirantSuo, createdTime=Thu Dec 05 08:36:00 CST 2019, time=2019-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418686, encodeId=0e7b1418686df, content=<a href='/topic/show?id=b07e8041efb' target=_blank style='color:#2F92EE;'>#耐药菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80417, encryptionId=b07e8041efb, topicName=耐药菌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10723392161, createdName=xiaoshitou, createdTime=Sat Aug 31 14:36:00 CST 2019, time=2019-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1522645, encodeId=2e19152264509, content=<a href='/topic/show?id=e4084348856' target=_blank style='color:#2F92EE;'>#多重耐药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43488, encryptionId=e4084348856, topicName=多重耐药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=476711462137, createdName=gao_jian4221, createdTime=Sat Aug 31 14:36:00 CST 2019, time=2019-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1524288, encodeId=f0dd152428890, content=<a href='/topic/show?id=053710045ad' target=_blank style='color:#2F92EE;'>#iron#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10045, encryptionId=053710045ad, topicName=iron)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f1b11597510, createdName=july_979, createdTime=Sat Aug 31 14:36:00 CST 2019, time=2019-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601079, encodeId=e35516010e963, content=<a href='/topic/show?id=a524434943e' target=_blank style='color:#2F92EE;'>#多重耐药菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43494, encryptionId=a524434943e, topicName=多重耐药菌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=646d18833414, createdName=lanyan20020092, createdTime=Sat Aug 31 14:36:00 CST 2019, time=2019-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=371986, encodeId=18c33e1986f4, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/01/577acf4668c2eb760152040cdd4c4196.jpg, createdBy=dc3f5107879, createdName=最帅小男护, createdTime=Fri Aug 30 00:17:31 CST 2019, time=2019-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=371984, encodeId=c71a3e19845b, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Thu Aug 29 23:48:09 CST 2019, time=2019-08-29, status=1, ipAttribution=)]
    2019-12-05 AspirantSuo
  2. [GetPortalCommentsPageByObjectIdResponse(id=1633532, encodeId=f2f8163353236, content=<a href='/topic/show?id=377824e1c0' target=_blank style='color:#2F92EE;'>#ANA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2471, encryptionId=377824e1c0, topicName=ANA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=434d22047430, createdName=AspirantSuo, createdTime=Thu Dec 05 08:36:00 CST 2019, time=2019-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418686, encodeId=0e7b1418686df, content=<a href='/topic/show?id=b07e8041efb' target=_blank style='color:#2F92EE;'>#耐药菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80417, encryptionId=b07e8041efb, topicName=耐药菌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10723392161, createdName=xiaoshitou, createdTime=Sat Aug 31 14:36:00 CST 2019, time=2019-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1522645, encodeId=2e19152264509, content=<a href='/topic/show?id=e4084348856' target=_blank style='color:#2F92EE;'>#多重耐药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43488, encryptionId=e4084348856, topicName=多重耐药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=476711462137, createdName=gao_jian4221, createdTime=Sat Aug 31 14:36:00 CST 2019, time=2019-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1524288, encodeId=f0dd152428890, content=<a href='/topic/show?id=053710045ad' target=_blank style='color:#2F92EE;'>#iron#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10045, encryptionId=053710045ad, topicName=iron)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f1b11597510, createdName=july_979, createdTime=Sat Aug 31 14:36:00 CST 2019, time=2019-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601079, encodeId=e35516010e963, content=<a href='/topic/show?id=a524434943e' target=_blank style='color:#2F92EE;'>#多重耐药菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43494, encryptionId=a524434943e, topicName=多重耐药菌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=646d18833414, createdName=lanyan20020092, createdTime=Sat Aug 31 14:36:00 CST 2019, time=2019-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=371986, encodeId=18c33e1986f4, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/01/577acf4668c2eb760152040cdd4c4196.jpg, createdBy=dc3f5107879, createdName=最帅小男护, createdTime=Fri Aug 30 00:17:31 CST 2019, time=2019-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=371984, encodeId=c71a3e19845b, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Thu Aug 29 23:48:09 CST 2019, time=2019-08-29, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1633532, encodeId=f2f8163353236, content=<a href='/topic/show?id=377824e1c0' target=_blank style='color:#2F92EE;'>#ANA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2471, encryptionId=377824e1c0, topicName=ANA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=434d22047430, createdName=AspirantSuo, createdTime=Thu Dec 05 08:36:00 CST 2019, time=2019-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418686, encodeId=0e7b1418686df, content=<a href='/topic/show?id=b07e8041efb' target=_blank style='color:#2F92EE;'>#耐药菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80417, encryptionId=b07e8041efb, topicName=耐药菌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10723392161, createdName=xiaoshitou, createdTime=Sat Aug 31 14:36:00 CST 2019, time=2019-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1522645, encodeId=2e19152264509, content=<a href='/topic/show?id=e4084348856' target=_blank style='color:#2F92EE;'>#多重耐药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43488, encryptionId=e4084348856, topicName=多重耐药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=476711462137, createdName=gao_jian4221, createdTime=Sat Aug 31 14:36:00 CST 2019, time=2019-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1524288, encodeId=f0dd152428890, content=<a href='/topic/show?id=053710045ad' target=_blank style='color:#2F92EE;'>#iron#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10045, encryptionId=053710045ad, topicName=iron)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f1b11597510, createdName=july_979, createdTime=Sat Aug 31 14:36:00 CST 2019, time=2019-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601079, encodeId=e35516010e963, content=<a href='/topic/show?id=a524434943e' target=_blank style='color:#2F92EE;'>#多重耐药菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43494, encryptionId=a524434943e, topicName=多重耐药菌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=646d18833414, createdName=lanyan20020092, createdTime=Sat Aug 31 14:36:00 CST 2019, time=2019-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=371986, encodeId=18c33e1986f4, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/01/577acf4668c2eb760152040cdd4c4196.jpg, createdBy=dc3f5107879, createdName=最帅小男护, createdTime=Fri Aug 30 00:17:31 CST 2019, time=2019-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=371984, encodeId=c71a3e19845b, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Thu Aug 29 23:48:09 CST 2019, time=2019-08-29, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1633532, encodeId=f2f8163353236, content=<a href='/topic/show?id=377824e1c0' target=_blank style='color:#2F92EE;'>#ANA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2471, encryptionId=377824e1c0, topicName=ANA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=434d22047430, createdName=AspirantSuo, createdTime=Thu Dec 05 08:36:00 CST 2019, time=2019-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418686, encodeId=0e7b1418686df, content=<a href='/topic/show?id=b07e8041efb' target=_blank style='color:#2F92EE;'>#耐药菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80417, encryptionId=b07e8041efb, topicName=耐药菌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10723392161, createdName=xiaoshitou, createdTime=Sat Aug 31 14:36:00 CST 2019, time=2019-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1522645, encodeId=2e19152264509, content=<a href='/topic/show?id=e4084348856' target=_blank style='color:#2F92EE;'>#多重耐药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43488, encryptionId=e4084348856, topicName=多重耐药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=476711462137, createdName=gao_jian4221, createdTime=Sat Aug 31 14:36:00 CST 2019, time=2019-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1524288, encodeId=f0dd152428890, content=<a href='/topic/show?id=053710045ad' target=_blank style='color:#2F92EE;'>#iron#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10045, encryptionId=053710045ad, topicName=iron)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f1b11597510, createdName=july_979, createdTime=Sat Aug 31 14:36:00 CST 2019, time=2019-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601079, encodeId=e35516010e963, content=<a href='/topic/show?id=a524434943e' target=_blank style='color:#2F92EE;'>#多重耐药菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43494, encryptionId=a524434943e, topicName=多重耐药菌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=646d18833414, createdName=lanyan20020092, createdTime=Sat Aug 31 14:36:00 CST 2019, time=2019-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=371986, encodeId=18c33e1986f4, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/01/577acf4668c2eb760152040cdd4c4196.jpg, createdBy=dc3f5107879, createdName=最帅小男护, createdTime=Fri Aug 30 00:17:31 CST 2019, time=2019-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=371984, encodeId=c71a3e19845b, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Thu Aug 29 23:48:09 CST 2019, time=2019-08-29, status=1, ipAttribution=)]
    2019-08-31 july_979
  5. [GetPortalCommentsPageByObjectIdResponse(id=1633532, encodeId=f2f8163353236, content=<a href='/topic/show?id=377824e1c0' target=_blank style='color:#2F92EE;'>#ANA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2471, encryptionId=377824e1c0, topicName=ANA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=434d22047430, createdName=AspirantSuo, createdTime=Thu Dec 05 08:36:00 CST 2019, time=2019-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418686, encodeId=0e7b1418686df, content=<a href='/topic/show?id=b07e8041efb' target=_blank style='color:#2F92EE;'>#耐药菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80417, encryptionId=b07e8041efb, topicName=耐药菌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10723392161, createdName=xiaoshitou, createdTime=Sat Aug 31 14:36:00 CST 2019, time=2019-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1522645, encodeId=2e19152264509, content=<a href='/topic/show?id=e4084348856' target=_blank style='color:#2F92EE;'>#多重耐药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43488, encryptionId=e4084348856, topicName=多重耐药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=476711462137, createdName=gao_jian4221, createdTime=Sat Aug 31 14:36:00 CST 2019, time=2019-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1524288, encodeId=f0dd152428890, content=<a href='/topic/show?id=053710045ad' target=_blank style='color:#2F92EE;'>#iron#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10045, encryptionId=053710045ad, topicName=iron)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f1b11597510, createdName=july_979, createdTime=Sat Aug 31 14:36:00 CST 2019, time=2019-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601079, encodeId=e35516010e963, content=<a href='/topic/show?id=a524434943e' target=_blank style='color:#2F92EE;'>#多重耐药菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43494, encryptionId=a524434943e, topicName=多重耐药菌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=646d18833414, createdName=lanyan20020092, createdTime=Sat Aug 31 14:36:00 CST 2019, time=2019-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=371986, encodeId=18c33e1986f4, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/01/577acf4668c2eb760152040cdd4c4196.jpg, createdBy=dc3f5107879, createdName=最帅小男护, createdTime=Fri Aug 30 00:17:31 CST 2019, time=2019-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=371984, encodeId=c71a3e19845b, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Thu Aug 29 23:48:09 CST 2019, time=2019-08-29, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1633532, encodeId=f2f8163353236, content=<a href='/topic/show?id=377824e1c0' target=_blank style='color:#2F92EE;'>#ANA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2471, encryptionId=377824e1c0, topicName=ANA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=434d22047430, createdName=AspirantSuo, createdTime=Thu Dec 05 08:36:00 CST 2019, time=2019-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418686, encodeId=0e7b1418686df, content=<a href='/topic/show?id=b07e8041efb' target=_blank style='color:#2F92EE;'>#耐药菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80417, encryptionId=b07e8041efb, topicName=耐药菌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10723392161, createdName=xiaoshitou, createdTime=Sat Aug 31 14:36:00 CST 2019, time=2019-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1522645, encodeId=2e19152264509, content=<a href='/topic/show?id=e4084348856' target=_blank style='color:#2F92EE;'>#多重耐药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43488, encryptionId=e4084348856, topicName=多重耐药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=476711462137, createdName=gao_jian4221, createdTime=Sat Aug 31 14:36:00 CST 2019, time=2019-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1524288, encodeId=f0dd152428890, content=<a href='/topic/show?id=053710045ad' target=_blank style='color:#2F92EE;'>#iron#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10045, encryptionId=053710045ad, topicName=iron)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f1b11597510, createdName=july_979, createdTime=Sat Aug 31 14:36:00 CST 2019, time=2019-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601079, encodeId=e35516010e963, content=<a href='/topic/show?id=a524434943e' target=_blank style='color:#2F92EE;'>#多重耐药菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43494, encryptionId=a524434943e, topicName=多重耐药菌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=646d18833414, createdName=lanyan20020092, createdTime=Sat Aug 31 14:36:00 CST 2019, time=2019-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=371986, encodeId=18c33e1986f4, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/01/577acf4668c2eb760152040cdd4c4196.jpg, createdBy=dc3f5107879, createdName=最帅小男护, createdTime=Fri Aug 30 00:17:31 CST 2019, time=2019-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=371984, encodeId=c71a3e19845b, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Thu Aug 29 23:48:09 CST 2019, time=2019-08-29, status=1, ipAttribution=)]
    2019-08-30 最帅小男护

    学习了

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1633532, encodeId=f2f8163353236, content=<a href='/topic/show?id=377824e1c0' target=_blank style='color:#2F92EE;'>#ANA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2471, encryptionId=377824e1c0, topicName=ANA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=434d22047430, createdName=AspirantSuo, createdTime=Thu Dec 05 08:36:00 CST 2019, time=2019-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418686, encodeId=0e7b1418686df, content=<a href='/topic/show?id=b07e8041efb' target=_blank style='color:#2F92EE;'>#耐药菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80417, encryptionId=b07e8041efb, topicName=耐药菌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10723392161, createdName=xiaoshitou, createdTime=Sat Aug 31 14:36:00 CST 2019, time=2019-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1522645, encodeId=2e19152264509, content=<a href='/topic/show?id=e4084348856' target=_blank style='color:#2F92EE;'>#多重耐药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43488, encryptionId=e4084348856, topicName=多重耐药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=476711462137, createdName=gao_jian4221, createdTime=Sat Aug 31 14:36:00 CST 2019, time=2019-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1524288, encodeId=f0dd152428890, content=<a href='/topic/show?id=053710045ad' target=_blank style='color:#2F92EE;'>#iron#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10045, encryptionId=053710045ad, topicName=iron)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f1b11597510, createdName=july_979, createdTime=Sat Aug 31 14:36:00 CST 2019, time=2019-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601079, encodeId=e35516010e963, content=<a href='/topic/show?id=a524434943e' target=_blank style='color:#2F92EE;'>#多重耐药菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43494, encryptionId=a524434943e, topicName=多重耐药菌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=646d18833414, createdName=lanyan20020092, createdTime=Sat Aug 31 14:36:00 CST 2019, time=2019-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=371986, encodeId=18c33e1986f4, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/01/577acf4668c2eb760152040cdd4c4196.jpg, createdBy=dc3f5107879, createdName=最帅小男护, createdTime=Fri Aug 30 00:17:31 CST 2019, time=2019-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=371984, encodeId=c71a3e19845b, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Thu Aug 29 23:48:09 CST 2019, time=2019-08-29, status=1, ipAttribution=)]
    2019-08-29 1209e435m98(暂无昵称)

    学习了

    0

Baidu
map
Baidu
map
Baidu
map